These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22530045)

  • 21. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression.
    Malanchi I; Accardi R; Diehl F; Smet A; Androphy E; Hoheisel J; Tommasino M
    J Virol; 2004 Dec; 78(24):13769-78. PubMed ID: 15564485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S-phase lengthening induced by p16(INK4a) overexpression in malignant cells with wild-type pRb and p53.
    Chien WW; Domenech C; Catallo R; Salles G; Ffrench M
    Cell Cycle; 2010 Aug; 9(16):3286-96. PubMed ID: 20703084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human papillomavirus E6/E7 genes induce discordant changes in the expression of cell growth regulatory proteins.
    Pei XF
    Carcinogenesis; 1996 Jul; 17(7):1395-401. PubMed ID: 8706240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
    Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
    Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human papillomavirus E6 oncogene represses a cell adhesion pathway and disrupts focal adhesion through degradation of TAp63β upon transformation.
    Ben Khalifa Y; Teissier S; Tan MK; Phan QT; Daynac M; Wong WQ; Thierry F
    PLoS Pathog; 2011 Sep; 7(9):e1002256. PubMed ID: 21980285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus type 38 alters wild-type p53 activity to promote cell proliferation via the downregulation of integrin alpha 1 expression.
    Romero-Medina MC; Venuti A; Melita G; Robitaille A; Ceraolo MG; Pacini L; Sirand C; Viarisio D; Taverniti V; Gupta P; Scalise M; Indiveri C; Accardi R; Tommasino M
    PLoS Pathog; 2020 Aug; 16(8):e1008792. PubMed ID: 32813746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis.
    Muench P; Probst S; Schuetz J; Leiprecht N; Busch M; Wesselborg S; Stubenrauch F; Iftner T
    Cancer Res; 2010 Sep; 70(17):6913-24. PubMed ID: 20663910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells.
    Tian Y; Chen H; Qiao L; Zhang W; Zheng J; Zhao W; Chen JJ; Zhang W
    J Cell Mol Med; 2018 Sep; 22(9):4150-4160. PubMed ID: 29893470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes.
    Marthaler AM; Podgorska M; Feld P; Fingerle A; Knerr-Rupp K; Grässer F; Smola H; Roemer K; Ebert E; Kim YJ; Bohle RM; Müller CSL; Reichrath J; Vogt T; Malejczyk M; Majewski S; Smola S
    PLoS Pathog; 2017 Jun; 13(6):e1006406. PubMed ID: 28640877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The initiation of UV-induced G(1) arrest in human cells is independent of the p53/p21/pRb pathway but can be attenuated through expression of the HPV E7 oncoprotein.
    Loignon M; Drobetsky EA
    Carcinogenesis; 2002 Jan; 23(1):35-45. PubMed ID: 11756221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation.
    Chao HH; Buchmann AM; DeCaprio JA
    Mol Cell Biol; 2000 Oct; 20(20):7624-33. PubMed ID: 11003658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulated ΔNp63α inhibits expression of Ink4a/arf, blocks senescence, and promotes malignant conversion of keratinocytes.
    Ha L; Ponnamperuma RM; Jay S; Ricci MS; Weinberg WC
    PLoS One; 2011; 6(7):e21877. PubMed ID: 21789189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papilloma.
    Altavilla G; Staffieri A; Busatto G; Canesso A; Giacomelli L; Marioni G
    Acta Otolaryngol; 2009 Nov; 129(11):1242-9. PubMed ID: 19863319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV infection and the alterations of the pRB pathway in oral carcinogenesis.
    Lim KP; Hamid S; Lau SH; Teo SH; Cheong SC
    Oncol Rep; 2007 Jun; 17(6):1321-6. PubMed ID: 17487385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
    Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.